HydroVal

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of HydroVal

Quick Facts

Property Description
Active Ingredient Hydrocortisone valerate
Form Topical formulation (Cream or Ointment)
Pharmacological Class Corticosteroid (Glucocorticoid)
General Purpose Relief of inflammation and pruritus (itching)
Origin Synthetic

Classification and Active Composition

HydroVal is a pharmaceutical preparation classified as a potent topical corticosteroid, distinguished by its active ingredient, Hydrocortisone valerate. This compound belongs to the pharmacological class of Glucocorticoids, which are agents used to suppress localized inflammatory responses in the skin. The Hydrocortisone valerate contained in the product is a synthetic derivative of the natural hormone Cortisol and functions as a single-ingredient anti-inflammatory agent. This classification as a medium-potency corticosteroid is clinically recognized for effective dermal penetration, ensuring targeted action.


Dosage Form and General Purpose

HydroVal is available as a topical formulation, most commonly presented as a cream or an ointment, designed for topical administration directly to the skin's surface. These forms are engineered to deliver the active compound, with the choice of the hydrophilic base (cream) or the thicker emollient base (ointment) depending on the desired vehicle. The primary role of the active ingredient is the management of skin disorders by targeting inflammation. This confirms that the general therapeutic purpose of this preparation is to provide targeted relief from the core symptoms of various dermatological conditions, such as flare-ups characterized by intense localized inflammation and the associated sensation of pruritus (itching).


Why is HydroVal Used for Skin Inflammation?

HydroVal is utilized because its Glucocorticoid action enables the rapid suppression of the local immune and inflammatory responses that lead to the physical signs of irritation. By modulating cellular activity, the compound helps to dampen the excessive cellular reactions responsible for swelling, redness, and heat. This effect provides the distinct practical benefit of stabilizing the compromised skin barrier and quickly mitigating discomfort, confirming its role as a targeted anti-inflammatory agent for managing acute or chronic localized skin issues.

What side effects are possible with HydroVal?

Possible Side Effects and Safety Information

The safety profile for HydroVal (hydrocortisone valerate) is defined by officially documented adverse reactions that affect both the application site and the body's systems due to percutaneous absorption of the potent corticosteroid.

Documented Adverse Reactions

The most frequently reported adverse reactions are local dermatological effects that occur at the application site. These include burning, itching, irritation, dryness, and redness. Other local effects documented, especially with prolonged use or the use of occlusive dressings, are folliculitis, hypertrichosis (increased hair growth), acneiform eruptions, and hypopigmentation (skin lightening). The potential for permanent skin changes, such as skin atrophy (thinning) and striae (stretch marks), is listed as an infrequent, but documented, risk associated with treatment duration.

System-Organ Class Examples of Documented Adverse Reactions
Skin and Subcutaneous Tissue Burning, Pruritus, Irritation, Skin Atrophy, Striae
Endocrine System HPA Axis Suppression, Cushing's Syndrome Manifestations
Nervous System Intracranial Hypertension (in pediatric patients)

Serious Systemic Risks and Safety Constraints

The most clinically significant adverse reaction documented by regulatory authorities is Hypothalamic-Pituitary-Adrenal (HPA) axis suppression. This serious effect is a risk associated with the systemic absorption of the active ingredient and may lead to signs of glucocorticosteroid insufficiency after treatment cessation. Manifestations of Cushing's syndrome are also documented as a possible systemic consequence.

Regulatory safety notes emphasize that the risk of systemic absorption is augmented by applying the product over large surface areas, for prolonged periods, or by using occlusive dressings. Furthermore, pediatric patients are officially noted to be at a significantly greater risk for systemic toxicity, including HPA axis suppression and associated effects such as linear growth retardation, due to their higher skin surface area to body mass ratio.

Overdose and Emergency Response

The official regulatory profile for HydroVal (hydrocortisone valerate) overdose centers on the risk of systemic toxicity resulting from excessive absorption through the skin, rather than acute overdose. This scenario is associated with the prolonged application of the preparation, use over extensive body surface areas, or application under occlusive dressings.

The documented physiological finding of overdose is Hypothalamic-Pituitary-Adrenal (HPA) Axis Suppression, which may present with manifestations consistent with Cushing’s syndrome. Monitoring for HPA axis suppression involves specific laboratory tests, such as the ACTH stimulation test or urinary free cortisol. Other documented signs of excess systemic absorption include hyperglycemia and glucosuria.

When to Seek Help

Urgent medical attention is required if signs of glucocorticosteroid insufficiency occur, particularly upon or following the reduction or cessation of topical use. This condition may necessitate the administration of supplemental systemic corticosteroids as part of supportive management. If HPA suppression is noted, the recommended actions involve attempting to withdraw the drug or reduce the frequency of application. No specific antidote is officially documented for systemic overdose.

Specific Considerations

Pediatric patients are noted to have a greater susceptibility to systemic overdose effects, including HPA axis suppression, delayed weight gain, and the rare occurrence of intracranial hypertension.

Therapeutic Uses of HydroVal

Quick Facts: What HydroVal Treats

  • Relief of Symptoms: May assist in managing the redness and discomfort (pruritus) associated with certain skin conditions.
  • Dermatoses: Approved for use in skin conditions that respond to corticosteroid therapy.
  • Inflammatory Manifestations: Helps address the visible signs of inflammation in the skin.

What HydroVal Treats: Main Uses and Benefits

HydroVal (hydrocortisone valerate) is a prescription topical medication primarily designated for individuals who have corticosteroid-responsive dermatoses. This class of skin conditions includes various inflammatory and itchy presentations that show improvement with this type of treatment.

The application of this medication is indicated for the relief of the inflammatory and pruritic manifestations that occur with these conditions. Pruritus refers to the symptom of itching, and addressing this may contribute to enhanced comfort for the patient. The medication's purpose is to manage the visible signs and sensations associated with the skin disorder.

Use of this product should be part of a comprehensive management plan directed by a qualified healthcare professional. It is utilized to provide a beneficial change in the severity of symptoms for the approved therapeutic domains, which are classified as medium-potency corticosteroid-responsive skin conditions.

This medication is not intended for the treatment of conditions other than those for which it was specifically prescribed. It serves to moderate inflammatory responses in the affected skin areas.

Eligibility and Restrictions for Use

HydroVal (hydrocortisone valerate) is a topical, medium-potency corticosteroid prescribed to relieve the inflammation and itching associated with various skin conditions that respond to steroid treatment.

Who Can Use HydroVal

Generally, this medication is intended for adult patients with diagnosed corticosteroid-responsive dermatoses. Use in children and infants should be determined by a healthcare provider, as pediatric patients may be more susceptible to systemic side effects like adrenal gland suppression due to their higher skin surface area to body weight ratio.


Who Cannot Use HydroVal (Contraindications)

HydroVal is contraindicated and should not be used in individuals with a known hypersensitivity or allergy to hydrocortisone valerate or any other ingredient in the formulation.

It is also generally advised not to use this medication on:

  • Skin Infections: Untreated bacterial, fungal, or viral infections (e.g., herpes, chickenpox, tuberculosis of the skin, or syphilitic skin infections) as corticosteroids may worsen or mask symptoms.
  • Certain Areas: The face, groin, or underarms unless specifically directed by a physician.
  • Near the Eyes: To avoid contact, as systemic absorption may increase the risk of glaucoma or cataracts.

Special caution is required for patients with pre-existing conditions like Cushing's syndrome or diabetes, as topical corticosteroid absorption can potentially exacerbate these conditions. If you are pregnant or breastfeeding, discuss the potential risks versus benefits with your doctor.

What should I know about interactions with other medicines?

Interactions with other medicines and products

For HydroVal (hydrocortisone valerate), the official regulatory profile focuses on factors that augment systemic absorption of the active ingredient, as classic drug-drug metabolic interactions are not specifically documented in the available prescribing information.

Official Exposure-Modifying Conditions

Systemic exposure of the topical medication is formally documented to increase when specific administration conditions are present. These factors are considered interaction constraints due to their ability to augment the drug's passage into the bloodstream, increasing the potential for systemic effects.

Condition Augmenting Systemic Exposure Effect Classification
Use of occlusive dressings Exposure-Augmenting Constraint
Application over large surface areas Exposure-Augmenting Constraint
Prolonged duration of use Exposure-Augmenting Constraint
Inflammation or compromised skin integrity Exposure-Augmenting Constraint

Pharmacodynamic Interaction Profile

Augmented systemic exposure may produce pharmacodynamic interactions with the body’s endogenous endocrine system. These effects include the potential for reversible hypothalamic-pituitary-adrenal (HPA) axis suppression and manifestations consistent with Cushing's syndrome. The label also notes the potential for metabolic effects such as hyperglycemia and glucosuria resulting from sufficient systemic absorption.

Population-Specific Interaction Vulnerability

Pediatric patients are formally identified as having a greater risk for these systemic interactions (HPA axis suppression, Cushing's syndrome). This vulnerability is attributed to their larger skin surface area to body mass ratio, which increases systemic exposure when compared to adults.

Mechanism of Action

How HydroVal Works: Mechanism of Action

HydroVal's active ingredient is an agonist of the intracellular Glucocorticoid Receptor ( GR), initiating a change in cellular programming. This complex enters the nucleus to modulate gene expression, simultaneously up-regulating anti-inflammatory proteins via transactivation and suppressing the transcription of pro-inflammatory signals (e.g., cytokines) via transrepression. This molecular shift results in the modulation of the local physiological response.

The genomic action promotes the synthesis of proteins like Lipocortin-1, which indirectly inhibits the key enzyme Phospholipase A2 ( PLA2). By blocking PLA2, the drug cuts off the supply of the precursor molecule, arachidonic acid, preventing the synthesis of inflammatory chemical mediators such as prostaglandins and leukotrienes. This inhibition of the pathway at an upstream step contributes to the suppression of the local inflammatory signaling cascade.

The drug influences local tissue dynamics by inducing vasoconstriction and reducing the permeability of small blood vessels. This action limits the leakage of fluid and proteins into the tissue, which in turn reduces tissue exudation. Furthermore, the mechanism impairs the activation and migration of specific immune cells into the affected area, contributing to the physiological consequence of decreased cellular infiltration and modulating the tissue's physiological state.

Dosage and Administration Information

Official Administration Guidelines

HydroVal is officially intended for topical administration only, meaning the 0.2% cream or ointment must be applied directly to the surface of the skin. The medication is classified as a medium-potency corticosteroid, and its usage protocol is specifically structured around managing local skin conditions while limiting systemic exposure.

Dosing and Frequency

The standard labeled regimen for adults involves applying a thin film of the preparation to the affected skin area. This is typically done two or three times daily, as determined by the prescribing physician. The primary objective is to use the least amount of medication necessary to achieve control of the dermatological condition.

Administration Constraints and Duration

Several procedural constraints define the proper use protocol. The treated skin area must not be covered, bandaged, or wrapped with an occlusive dressing unless explicitly instructed by a healthcare provider. Furthermore, official guidance states that the cream or ointment should not be applied to the face, underarms, or groin unless a doctor specifically advises it.

Treatment duration is limited to the time required to manage the symptoms; therapy should be discontinued when control is achieved. If a patient observes no visible improvement within two weeks of initiating the labeled schedule, the original diagnosis requires mandatory reassessment. For pediatric patients, strict constraints apply: administration must be limited to the lowest effective amount, and the product should not be used in the diaper area, as this may increase systemic exposure.

Recent Clinical Evidence

Research Evidence / Overview of Studies for HydroVal


Evidence for Use in Corticosteroid-Responsive Dermatoses

Research into HydroVal (hydrocortisone valerate) has primarily involved short-term Randomized Controlled Trials (RCTs), which are a common type of study design for clinical investigations. These studies were used in research exploring how symptoms change over time in adult patients diagnosed with various inflammatory skin conditions that are generally known to respond to this type of medicine.

The trials were designed to measure changes in overall disease severity scores as assessed by clinicians, and they monitored outcomes related to inflammatory or irritative states, such as redness and swelling. Additionally, studies was evaluated in relation to patient-reported outcomes describing perceived discomfort, including measures of pruritus (itching) change. Findings describe patterns observed in the studies where outcomes related to these physical discomforts were observed across defined time intervals.

However, the evidence base for this general indication often includes data from the broader evidence landscape established for the entire class of medium-potency topical corticosteroids. Long-term effects are not fully established, and there is limited information for long-term outcomes regarding potential use patterns beyond the resolution of the acute episode.


Evidence for Atopic Dermatitis (Eczema)

Specific research has studied for HydroVal in treating mild to moderate atopic dermatitis (eczema), a condition characterized by fluctuating or episodic manifestations. This evidence includes comparative Randomized Controlled Trials (RCTs) and Systematic Reviews that explore different corticosteroid strengths. These studies examined outcomes reflecting daily functioning or activity level and utilized standardized measures to assess the degree of change in overall disease severity.

Research has explored how symptoms evolved in the observed populations, and findings indicate that changes were measured in key disease severity scores and in the degree of clinical clearing achieved during the study periods. The data show patterns related to how the medication was evaluated in comparison to other agents commonly was studied for atopic dermatitis. While evidence suggests patterns in studies focusing on episodes where symptoms become more noticeable, follow-up durations were limited primarily to the short term, focused on initial control.


Research Consistency and Remaining Uncertainty

The research for HydroVal is based on a foundation of Randomized Controlled Trials (RCTs), but the evidence quality varies across studies, particularly when comparing product-specific data versus data for the entire medium-potency corticosteroid class. The evidence highlights what is known—and what is still uncertain. For instance, the long-term effects are not fully established. Comparative evidence is lacking in some areas, and the results apply only to the populations studied and the specific conditions of the trials.

Key Studies & References

  1. Label: HYDROCORTISONE VALERATE OINTMENT USP, 0.2% - Regulatory Information and Indications
  2. Comparative efficacy of hydrocortisone valerate 0.2 percent ointment in the treatment of atopic dermatitis (Double-blind multicenter trial)

Frequently Asked Questions (FAQ)

Common questions about HydroVal (FAQ)

Q: Is HydroVal a prescription-only medicine?

A: Hydrocortisone valerate topical is generally classified as a prescription-only medicine in many regions. This means that official regulations require it to be prescribed by a licensed healthcare professional before it can be dispensed.


Q: What kind of condition is HydroVal specifically approved to treat?

A: Official documents state that the product is indicated for the relief of the inflammation and itching (pruritus) associated with corticosteroid-responsive dermatoses. This includes various inflammatory skin conditions such as eczema and dermatitis.


Q: Do I need to take HydroVal every day?

A: The frequency of application is determined by the prescribing physician. According to administration guidelines, the use of this medication is typically discontinued when the condition is controlled, meaning daily application is generally limited to the period of symptoms.


Q: Are there any common supplements or vitamins that should not be taken with HydroVal?

A: The official product information does not specifically document unique drug-drug metabolic interactions for the topical formulation. However, regulatory authorities generally indicate that patients should inform their doctor or pharmacist of all nonprescription medicines, vitamins, and herbal products they are taking for assessment.


Q: Can a person stop taking HydroVal suddenly without issues?

A: Official warnings note that sufficient systemic absorption of topical corticosteroids carries the risk of Hypothalamic-Pituitary-Adrenal (HPA) axis suppression. Following cessation, there is a potential for glucocorticosteroid insufficiency, which is a documented risk associated with HPA axis suppression.


Q: Is it common to feel slightly dizzy when first starting HydroVal?

A: Dizziness and other Central Nervous System (CNS) effects are reported side effects associated with systemic corticosteroid exposure. Although the potential is lower with topical application, these effects may be a factor due to systemic absorption, particularly with prolonged use or application over large areas.


Q: Does HydroVal affect or change a person's mood?

A: Mood changes, including symptoms like depression or anxiety, are documented as possible psychiatric adverse reactions associated with systemic corticosteroid exposure. If significant absorption of the topical medication occurs, mood changes are a factor patients may consider.


Q: Is HydroVal generally considered safe for older adults?

A: Regulatory information indicates that specific studies focusing solely on the relationship between age and the effects of hydrocortisone valerate in the geriatric population have not always been performed. Official documentation notes that the medication is generally used with caution in this population.


Q: Is there a generic version of HydroVal available?

A: The active ingredient in the product is Hydrocortisone Valerate, which is widely available in various generic topical formulations. The specific availability of the 0.2% concentration as a generic may vary based on market and regulatory approval history.


Q: What happens if I miss a dose of HydroVal?

A: Official guidance related to missed doses generally describes applying the medication as soon as it is remembered. If it is nearly time for the next application, guidance describes skipping the missed dose.


Q: Does HydroVal cause weight gain or weight loss?

A: Systemic absorption of corticosteroids may potentially lead to side effects such as weight gain or the manifestations consistent with Cushing's syndrome. This is an effect related to the body's internal hormone system, and the potential for this outcome is associated with greater absorption from the skin.


Q: Is it necessary to have routine blood tests while on HydroVal?

A: Official regulatory documents indicate that specific tests, such as the ACTH stimulation test, may be useful in evaluating patients for signs of HPA axis suppression. These tests are procedures that may be used during or after prolonged use, or when the product is applied over a large body surface area.


Q: Can a person take HydroVal if they have liver problems?

A: Official warnings note that corticosteroids are a factor for consideration in patients with pre-existing liver failure or significant liver problems. This is because liver impairment can potentially alter how the active ingredient is processed by the body.


Q: How long does the effect of one dose of HydroVal last?

A: Regulatory guidance on topical corticosteroids includes measuring the duration of the vasoconstrictor response (skin blanching or whitening) as a way to assess the pharmacological effect. The clinical effect is generally observed in regimens requiring application two or three times daily.


Q: Will HydroVal work if I have a mild case of the condition it treats?

A: Research evidence indicates that studies have examined HydroVal in the treatment of mild to moderate atopic dermatitis. Findings from clinical trials show documented changes in disease severity scores and monitored outcomes related to symptoms in the studied populations.


Q: Are there any specific foods that interact with HydroVal?

A: While direct food interactions with the topical form are not typically a primary concern, systemic corticosteroids have been documented to interact with certain foods, such as grapefruit. Dietary considerations are a topic to review with a healthcare provider.


Q: Is HydroVal considered a controlled substance?

A: Regulatory classification documents confirm that Hydrocortisone valerate is not classified as a controlled substance under the US Controlled Substances Act. This substance is not associated with classification as a narcotic or substance with high potential for abuse.


Q: Can women who are planning to become pregnant use HydroVal?

A: Official regulatory documents indicate that potential risks for women planning pregnancy are a topic for review with a physician. Some corticosteroids have demonstrated the potential for teratogenic effects (causing developmental issues) in animal studies following dermal application.


Q: What should I know about taking HydroVal if I have kidney issues?

A: Official regulatory warnings note that corticosteroids are a factor for consideration in individuals with renal insufficiency (kidney problems). Assessment may include frequent patient monitoring.


Q: Is it possible to develop a tolerance to HydroVal over time?

A: Regulatory documents do not specifically address drug tolerance (tachyphylaxis) for this product, but it is a known phenomenon for high-potency corticosteroids. Use beyond the point where the condition is controlled is generally not supported by official guidance.


Q: What official warnings or boxed statements apply to HydroVal?

A: A primary warning found in the official documents is the potential for Hypothalamic-Pituitary-Adrenal (HPA) axis suppression. This represents the most clinically significant systemic risk associated with the absorption of the topical corticosteroid into the body.


Q: Are headaches a common side effect when starting HydroVal?

A: Headaches are documented as a potential symptom of the serious systemic effect known as Intracranial Hypertension (primarily in children), or as a general side effect associated with systemic corticosteroid use.


Q: Can men with fertility concerns use HydroVal?

A: Systemic glucocorticoid excess is known to potentially affect the Hypothalamic-Pituitary-Gonadal (HPG) axis, which can impact testicular function and male fertility. Systemic risks of corticosteroid absorption are a factor for review with a doctor for men with pre-existing fertility concerns.


Q: Are there any known interactions between HydroVal and caffeine?

A: Official product information does not document a specific interaction with caffeine. However, all topical medications carry the possibility of systemic absorption, and individuals should report all substances they consume to their healthcare provider.


Q: Is HydroVal a narcotic or a habit-forming drug?

A: Official classification documents confirm that Hydrocortisone valerate is not designated as a narcotic or a habit-forming drug.


Q: Is it normal if HydroVal makes me feel a bit tired?

A: Feeling tired, weak, or dizzy are reported as potential systemic side effects associated with hydrocortisone. These symptoms may occur due to the systemic absorption of the topical product, especially if used over large areas.


Q: What is the evidence regarding HydroVal and driving ability?

A: Regulatory notes indicate that if systemic side effects such as feeling dizzy, weak, or tired occur, individuals may be advised to defer activities such as driving, cycling, or using machinery until they feel better. These effects are linked to systemic absorption.


Q: Does HydroVal interact with common cold or allergy medications?

A: The official documentation focuses on exposure-modifying conditions and pharmacodynamic effects rather than listing specific drug-drug metabolic interactions. It remains important to tell your physician about all cold and allergy medications you are using.


Q: Can people with high blood pressure take HydroVal?

A: Official warnings state that corticosteroids are a factor for consideration in individuals with pre-existing hypertension (high blood pressure) or congestive heart failure. Assessment may include frequent monitoring.


Q: Is HydroVal safe to use before surgery?

A: Regulatory guidance indicates that individuals using corticosteroids are typically instructed to inform their surgeon or dentist of their medication use. Dose adjustments may be a factor for consideration during periods of stress, such as an operation or dental procedure.


Q: Can HydroVal interact with herbal remedies?

A: Official regulatory sources note there is generally not enough information to confirm that complementary medicines and herbal remedies are safe to take concurrently with corticosteroids. Regulatory documents indicate that information about any herbal remedies or supplements being used is a factor for review with a healthcare provider.

How should HydroVal be stored and disposed of?

Storage and Disposal of Hydrocortisone Valerate (HydroVal)

Official regulatory guidelines strictly define how Hydrocortisone Valerate topical formulations must be stored to maintain stability.

Storage Requirements

The medication must be stored at Controlled Room Temperature, which is generally defined as 20 C to 25 C. It is mandatory to Protect from freezing and to keep the product in a closed container away from excessive heat, moisture, and direct light. For safety, always Keep out of the reach of children.


Disposal Instructions

Discard any unused or expired HydroVal according to official procedures. Patients are instructed to Ask your healthcare professional how you should dispose of any medicine you do not use. This ensures disposal aligns with local regulations and environmental guidelines, which often recommend drug take-back programs.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of HydroVal found in:

A-Z Index: